Shortage of Fluoxetine (Medreich) 10 mg capsule
1 Feb 2024
Policy
Fluoxetine (Medreich ®) for the treatment of major depressive disorders and obsessive-compulsive disorder is now listed on the Pharmaceutical Benefits Scheme (PBS) for the current supply shortage under Section 19A.
For more information on Fluoxetine (Medreich ®), please contact the PBS directly.
More news & views
25 July 2024
PBS prescriptions issued from outside Australia
PBS entitlements are valid only if issued from within Australia or territories listed in the Nationa...
18 July 2024
Telehealth Post-Implementation Review Final Report released
The Australian Government report reviews the appropriateness of telehealth and maintains the current...
18 July 2024
Update: Best Practice Resources
An update on the College’s new approach to high-quality resources